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Have increases in solar ultraviolet exposure contributed to the rise in
incidence of non-Hodgkin's lymphoma?
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Summary The incidence of non-Hodgkin's lymphoma (NHL) has increased substantially in many countries
over recent decades. The aetiology of this cancer is poorly understood, and this rise is largely unexplained. The
incidence of NHL is known to increase markedly following immune suppression. In the light of evidence that
exposure to ultraviolet radiation (UVR) may cause systemic immune suppression, part of the recent increase in
NHL incidence may reflect population-based increases in UVR exposure. That such exposure increases have
occurred is inferred from the widespread increases in skin cancer incidence in fair-skinned populations,
especially malignant melanoma (MM), over recent decades. Epidemiological evidence presented here in support
of the proposed UVR-NHL relationship includes the following: in Caucasian populations there is a moderate
positive correlation between ambient UVR level, by latitude, and NHL incidence; there is also a positive
correlation between time trends in MM incidence and NHL; there is some evidence that migration across
latitude gradients induces concordant shifts in risks of NHL and MM. Data from two historical cancer patient
registers show that, in individuals, these two cancers concurred a little more often than expected. These findings
support recent suggestions that UVR-induced impairment of immune functioning contributes to the aetiology
of NHL.
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The reported incidence of non-Hodgkin's lymphoma (NHL)
increased in cancer registry populations around the world by
20-50% every 5 years during the 1970s and 1980s (Coleman
et al., 1993; Hartge et al., 1994). These increases have
occurred in both Caucasian and non-Caucasian populations
and have been of similar magnitude in males and females.
They remain largely unexplained (Holford et al., 1992;
Hartge and Devesa, 1992). Temporal changes in diagnostic
practice and recording could account for a small part of this
increase, especially at older ages (Devesa and Fears, 1992;
Holford et al., 1992). However, high-grade UK regional data
indicate that substantial real increases have occurred
(Cartwright, 1992).
Some of the recent (post-1980) increase in NHL is
attributable to the onset of the AIDS epidemic (Rabkin et
al., 1991). For example, a 74% increase in NHL incidence
occurred between the mid-1970s and mid-1980s in young
white American men, aged 20-44 years, compared with a
16% increase in young women (Doll, 1991). Increased
occupational exposure to herbicides has been a widely
suggested cause, both in the USA and in other developed
countries (Morrison et al., 1992; Pearce and Bethwaite, 1992;
Hartge et al., 1993), although this seems incompatible with
the similar time trends in men and women. Overall, no more
than half of the 150% increase in NHL incidence in the USA
during 1950-85 can be explained by known or possible risk
factors (including pesticide exposure, hair dyes, diet, AIDS
and ionising radiation) (Devesa and Fears, 1992).
Meanwhile, in fair-skinned populations around the world,
the incidence of cutaneous malignant melanoma (MM) has
also increased by approximately 20-50% every 5 years over
the past two decades (Coleman et al., 1993; Armstrong and
Kricker, 1995). MM is acknowledged to be primarily due to
exposure to solar radiation, specifically ultraviolet radiation
(UVR) (IARC, 1992). These increases in incidence appear to
be non-artefactual (Van der Esch et al., 1991) and due to a
progressive increase in average levels of personal exposure to
UVR, reflecting changes in patterns of clothing and personal,
especially recreational, exposure (Armstrong and Kricker,
1993; Coleman et al., 1993).
It has recently been hypothesised that UVR may influence
the risk of NHL via its apparent immune suppressive effects
(Cartwright et al., 1994). If that were so, then the parallel
rises in NHL and MM over the past two decades, at least in
fair-skinned populations, might reflect a common aetiological
factor, that is a temporal increase in population-averaged
UVR exposure.
The incidence of NHL increases greatly in chronically
immune-suppressed persons (Greiner, 1994). In transplanta-
tion patients, this increase becomes evident within about 2
years of drug-induced immune suppression, and the risk
increases 20-fold or more (Kinlen, 1992; Opelz and
Henderson, 1993). In AIDS patients and in persons with
primary immunodeficiency, the risk of NHL is also increased
very substantially (Filipovich et al., 1992; Doll, 1991). The
incidence of NHL appears to be affected by immune
suppression much more markedly than that of any other
cancer.
There is a recent, growing body of evidence from studies
in laboratory animals and in humans that moderate levels of
ultraviolet irradiation of the skin cause local and systemic
immune suppression in mammals (Morison, 1989; Goettsch
et al., 1993; Jeevan and Kripke, 1993; Kripke, 1994). Various
studies in mice indicate that this effect is due to the UV-B
band (280-320 nm). There is substantial evidence of UV-
induced local immune suppression in the skin impairing both
contact and delayed-type hypersensitivity responses (Gianni-
ni, 1986; Yoshikawa et al., 1990; Goettsch et al., 1993;
Kripke, 1995). Ultraviolet irradiation also appears to cause
systemic suppression of cell-mediated immunity (Noonan and
De Fabo, 1990; Kripke, 1994). There is strong evidence from
many studies in mice, which, after UV irradiation, show a
reduced capacity to reject transplanted tumours (e.g. Kripke,
1981) and to respond to Mycobacterium bovis BCG (Jeevan
and Kripke, 1990).
The relevance to the human species of studies of external
UV-B exposure in (normally) fur-covered mice, with their
high ratio of surface area to body weight, is questionable.
The few studies of this topic in humans indicate that sunlight
exposure alters the profile of blood-borne T-cells (Hersey et
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al., 1983) and that localised UV-B exposure alters the
hypersensitivity response to antigen challenge at distant
non-irradiated skin sites (Cooper et al., 1992). UV-B
irradiation may induce a systemic effect via the release of
soluble mediators (such as interleukins and tumour necrosis
factor) in the skin, thereby altering the profile of
immunologically active T-lymphocytes for several days to
weeks after cessation of irradiation (Rivas & Ullrich, 1994;
Kripke, 1994). Although it has been reported that skin
pigmentation in humans does not influence the immunosup-
pressive effect of UV-B (Morison, 1989; Vermeer et al., 1991),
the evidence for this is tenuous.
To evaluate the relationship between NHL incidence and
exposure to UVR we have examined: (1) the relationship of
NHL incidence rates to ambient UVR levels in developed
country populations (cancer registration is much more
extensive and of generally higher quality in developed
countries); (2) the correlation between the time trends in
incidence of NHL and of MM; (3) changes in incidence of
these two cancers in several migrant populations; and (4) the
coincidence of these two malignancies within individuals.
Results
Correlation between ground level UV-B exposure and NHL
incidence
As an initial basic investigation, the cross-sectional relation-
ship between latitude and cancer incidence rates was
examined. Table I contains the average annual age-
standardised incidence rates for NHL and MM during
1978-87, for 49 cancer registries covering largely Caucasian
populations, as published in the two most recent volumes (V,
VI) of Cancer Incidence in Five Continents (Muir et al., 1987;
Parkin et al., 1992). The sample comprised every registry that
had published data in both volumes, had a base population
of at least 200 000 people, had a NHL histological
verification of at least 90%, and a NHL mortality-incidence
ratio of 75 or less.
Ground-level (ambient) UVR is approximately inversely
related to latitude (although average cloud cover, regional air
pollution and altitude also influence ambient UV irradiance).
The data for the registries are shown in ascending latitudinal
rank in northern and southern hemispheres. The assigned
Table I Incidence of NHL and MM in Caucasian populations, classified by dominant latitude
NHL Melanoma
Population Latitude Men Women Men Women
Iceland
Finland
Norway
Sweden
UK, north Scotland
UK, NE Scotland
Denmark
UK, east Scotland
UK, SE Scotland
UK, west Scotland
German Democratic Republic
Ireland, Southern
UK, Oxford
Netherlands, Eindhoven
Canada, Saskatchewan
Poland, Cracow City
France, Bas-Rhin
France, Calvados
Canada, Newfoundland
Czech Republic, Slovakia
France, Doubs
Switzerland, Basel
Canada, Alberta
Canada, New Brunswick
Switzerland, Zurich
France, Isere
Italy, Varese
Switzerland, Geneva
Switzerland, Vaud
Canada, Nova Scotia
Slovenia
Canada, British Columbia
Italy, Parma
US, Connecticut: White
US, Detroit: White
US, Alameda: White
US, Bay Area: White
Italy, Ragusa
US, Los Angeles: White
US, Atlanta: White
US, New Orleans: White
US, Hawaii: White
65N
62N
60N
59N
58N
57N
56N
56N
56N
56N
52N
52N
52N
51N
50N
5ON
49N
49N
48N
48N
48N
48N
47N
47N
47N
46N
46N
46N
46N
45N
45N
44N
44N
42N
42N
38N
38N
37N
34N
34N
30N
21N
4.9
7.9
7.1
8.4
7.8
7.8
7.4
7.8
7.9
7.5
5.3
5.9
7.0
8.4
10.6
3.8
9.7
6.2
5.5
5.4
5.7
10.6
10.1
9.9
9.1
6.8
10.5
10.0
11.8
8.3
4.7
10.7
6.9
11.6
12.6
11.9
14.4
5.3
11.8
11.0
11.4
11.4
3.1
5.3
5.2
5.4
5.5
5.9
5.0
5.9
6.8
5.4
3.4
4.9
5.0
4.9
8.0
2.0
5.5
4.6
4.2
2.7
4.1
6.1
7.4
6.5
5.7
4.6
5.8
5.5
6.5
6.6
2.9
7.4
4.8
8.5
9.0
8.2
8.9
2.6
8.2
7.9
8.7
7.4
3.1
5.7
9.7
8.4
4.1
3.3
6.8
3.8
4.0
3.5
3.4
3.3
3.1
4.1
5.4
3.1
4.1
3.3
3.0
3.3
3.4
8.1
5.3
4.0
8.5
2.3
3.7
8.8
7.6
5.5
3.0
8.2
2.6
9.5
8.2
11.0
11.8
2.9
13.5
13.2
5.9
22.5
5.4
5.5
12.0
8.9
6.2
4.9
9.1
6.1
6.3
5.6
4.0
7.6
5.7
6.2
6.9
4.0
5.4
5.2
3.6
3.7
5.2
8.1
6.2
5.5
10.5
3.3
4.1
9.1
8.7
6.3
3.4
9.4
3.5
8.1
6.8
9.9
10.0
1.8
11.3
10.2
5.0
16.9
Australia, Tasmania 42S 8.9 7.4 12.3 16.3
Australia, Victoria 38S 11.4 8.2 15.2 17.0
New Zealand: non-Maori 37S 7.9 5.5 17.1 22.2
Australia, ACT 35S 9.9 7.3 20.9 21.7
Australia, South 35S 11.1 8.1 15.9 18.4
Australia, NSW 34S 9.8 7.2 21.5 20.0
Australia, Western 32S 9.7 7.1 21.6 22.1
Annual rates overperiod 1978-87, standardised to world population andbased on rates published in CancerIncidence in Five Continents, Vols V
and VI.latitudes are those ofeither the city hosting the registry or the
capital city or largest conurbation within the registry
territory.
In the northern hemisphere there is a small and uneven
inverse latitudinal gradient for NHL in each sex. The rates
below 40'N are approximately 50% higher than rates above
50'N. However, within the USA, spanning 21-420N, there is
no gradient, nor is there a gradient evident within Canada.
The gradient for MM in the northern hemisphere (including
within the USA) is stronger than for NHL, although it too is
quite uneven. In the southern hemisphere, and depending on
Australasian data, there is a discrepancy between the
latitudinal gradients for the two cancers. The inverse
gradient for MM is clearcut but none is apparent for NHL.
Recently published cancer incidence data for England and
Wales, for 1968-85, show a clear latitude gradient for NHL;
southern rates are approximately double the northern rates
(Swerdlow and Dos Santos Silva, 1994). During 1953-73, the
mean daily duration of bright sunshine was approximately
50% greater in southern UK than in northern UK (Swerdlow
and Dos Santos Silva, 1994). The equivalent north-south
gradient for MM entails a 3- to 4-fold difference. For both
NHL and MM the gradient is a little stronger in men than in
women. Caution is needed in the interpretation of within-
country gradients for each of these cancers since, to the
extent that socioeconomic class (SES) is an independent risk
factor, the gradients may be confounded by latitudinal
differences in SES. Since the aetiology of NHL remains
uncertain, other latitude-related confounders may also be
present.
Since latitude is a proxy indicator of actual ambient UVR
level, we converted latitude to estimated UV-B exposure,
using data compiled by Diffey and Elwood (1994). These
authors have published four sets of estimates of year-round
cloud-adjusted ultraviolet irradiance by latitude: two of
minimal erythemal dose (MED, which essentially refers to
UV-B) and two of UV-A (each for the periods sunrise to
18.30 h and 11.30 to 12.30 h for each 100 of latitude from
60'N to 60'S. To estimate UVR exposure at intermediate
latitudes we fitted quadratic equations to each measure for
northern and southern latitudes separately (see example in
Figure 1). MED is the preferred index here, since UV-B, not
UV-A, is known to damage DNA and to perturb T-cell
profile.
Incidence rates ofNHL and MM, as reported for the male
white Caucasian populations from 49 registries identified in
Table I, were plotted against each of these four measures of
UVR. Since the UVR estimates are themselves highly
correlated, the linear regression slopes of cancer incidence
against each of the four UVR measures were very similar.
The plot of NHL incidence rates in relation to estimated
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day-long UV-B exposure, in men, shows a positive relation-
ship (Figure 2, r = 0.50). The equivalent data for MM in
men, in Figure 3, show a stronger association (r = 0.75). The
corresponding graphs for NHL (r = 0.51) and MM (r =
0.67) in women are similar to those for men. Each of these
correlation coefficients attained statistical significance at
P<0.001. Some of the 49 registry populations in Table I
contained small proportions of non-Caucasoid people with
olive or darker skin complexions. Although data were not
available to make appropriate adjustments, when the three
Italian registries were removed from the analysis the
correlation coefficients for males increased to 0.54 and 0.78,
for NHL and MM, and those for women increased to 0.57
and 0.72.
In interpreting these correlation analyses, two caveats are
necessary. An assumption is being made that a contemporary
measure of ambient UVR level is a valid index of average
UVR exposures over recent decades. Further, it is uncertain
to what extent ambient UVR level is a quantitative index of
actual average biologically effective exposure, since the effect
depends on the action spectrum and the additivity of
wavelength-specific effects (Munakata, 1993), and since the
received exposure is modulated by the built environment and
personal behaviour.
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Figure 2 Scatter plot for age-standardised incidence of non-
Hodgkin's lymphoma in men against estimated daily UV-B dose
(by dominant latitude for each registry population). Pearson's r
= 0.50. (Age standardisation is to world population. Incidence
data are from Parkin et al., 1992).
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Figure 1 Relationship of latitude, in northern and southern
hemispheres, to daily UV-B exposure (sunrise to 18:30h),
measured as minimal erythemal dose units. Interpolated values
have been estimated from data in Diffey and Elwood (1994).
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Figure 3 Scatter plot for age-standardised incidence ofmalignant
melanoma in men against estimated daily UV-B dose (by
dominant latitude for each registry population). Pearson's r =
0.75. (Age standardisation is to world population. Incidence data
are from Parkin et al., 1992).
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Correlation between time-trends in MM and NHL during
1970-85
The cancer incidence data from Volumes I-VI of Cancer
Incidence in Five Continents, from continuously reporting,
quality-controlled, population-based cancer registries around
the world have recently been collated for formal analysis of
longitudinal time trends in incidence (Coleman et al., 1993).
That analysis was restricted to the age range 30-74, and all
incidence rates were age standardised across population, time
and sex. For each population, the average quinquennial
percentage change in incidence over the period 1970-85 was
calculated for men and women separately. We have here used
those percentage changes (predominantly increases) to
determine the correlation between registry-specific changes
in MM and in NHL incidence for men and women
separately. The results are summarised in Table II.
Overall, there is a moderate positive correlation between
these registry-specific time trends, measured as percentage
change. After excluding the one obvious outlier (Zaragoza,
Spain, for women), the correlation coefficients are in the
range 0.3-0.4. In men the correlation is stronger in the
subset of Caucasian populations (r = 0.41, P = 0.014) than
in all populations combined. This difference is compatible
with the general observation that MM incidence is responsive
to increased solar exposure in fair-skinned but not dark-
skinned populations. For women, however, exclusion of
darker skinned populations did not affect the strength of
correlation.
Changes in rates of NHL and MM in migrant populations
Migrants moving between countries often experience shifts in
cancer risk relative to risk in their country of origin. Such
shifts may be due to a change in environmental exposures.
Cancer incidence data from the population-based registry in
Victoria, Australia (Giles et al., 1992), show a shift in both
NHL and MM rates in British-born migrants towards the
higher rates in the Australian-born and away from the lower
rates in England and Wales (Table III). This suggests that
there is an added environmental factor influencing the risks
ofeach of these two cancers. The relatively greater increase in
risk of NHL, compared with MM, would accord with UVR
exposure being important in childhood (i.e. premigration) in
the aetiology of MM (Armstrong and Kricker, 1995), but
relatively more important in later adulthood for NHL upon
which it has a late-stage effect (Kinlen, 1992).
Second primary cancers: are MM and NHL associated?
Data from Connecticut, USA (1935-82), and Denmark
(1940-80) on the incidence of second primary cancers in
cancer patients allow determination of the concurrence of
NHL and MM in individuals (National Cancer Institute,
1985). In each register, long-term follow-up was achieved for
most patients, and approximately one-quarter of the second
primary cancers occurred at least 10 years after diagnosis of
the first primary cancer.
In patients with NHL as first primary cancer, there were
11 MM vs 5.75 expected from general population incidence
rates. That gives a relative risk of 1.9, which exceeds the
relative risk for all second (non-NHL) primaries in NHL
patients (RR = 1.1). In persons with MM as a first primary
there were 8 NHL vs 10.56 expected. The former comparison
may be the more relevant here since an increase in personal
exposure to UVR would be expected to affect, via a short-
latency process, NHL risk before affecting MM via a
(presumably) longer latency process. It is of interest that a
recent study of a large composite Swedish-Danish cohort of
cancer patients found a 2.4-fold increase in risk of MM
following NHL, but a lesser 1.4-fold increase in NHL
following MM (Adami et al., 1995).
In case either MM or NHL were susceptible to detection
bias in the follow-up of cancer patients, we examined both
NHL and MM as second primary cancers in persons with
colon cancer as the primary cancer. Their relative risks for
subsequent NHL or MM were indistinguishable from the
figure for all second primaries. Thus, within this data set,
neither MM nor NHL appears to have been prone to
detection bias.
Discussion
The three descriptive epidemiological analyses indicate, first,
that there is a moderate positive cross-sectional geographic
correlation between ambient levels of UV-B and the incidence
of non-Hodgkin's lymphoma; second, that time trends in the
incidence of malignant melanoma and NHL are positively
correlated; and, third, that British migrants to higher UVR
Australia exhibit an upwards shift in the risks of both NHL
and MM.
The correlation data shown in Table II are based on
concurrent time trends in the incidence of the two cancers.
This approach would be optimal if the aetiological influence
Table II Correlation between percentage increases in the incidence of MM and NHL, during the period 1970-85, for men and women
separately. Data are from population-based cancer registries (Coleman et al., 1993)
Number of Correlation coefficient
populations
Population (women/men) Women Men
All populations 48/51 0.43 (0.26)a 0.24
(0.002)b (0.076) (0.095) All, minus Black, Maori, Indian 43/46 0.50 (0.32) 0.36
(0.001) (0.038) (0.015)
Caucasian populations 34/36 0.61 (0.29) 0.41
(0.0001) (0.099) (0.014)
a Zaragoza, Spain, has unusually high rates ofincrease for both malignancies in women. The correlationcoefficient with those data omitted is
given in parentheses. bP-value
Table m World-standardised annual incidence rates (per 100000) of NHL and MM in the mid-1980s: British migrants to Victoria, Australia,
compared with the Australian-born population and the population of England and Wales
Cancer Sex Australian-born British migrants England and Wale?
NHL Men 12.4 11.1 7.1
Women 8.7 8.2 4.8
MM Men 21.0 11.1 3.0
Women 22.7 15.3 5.0
a Cancer Incidence in Five Continents, Vol. VI (Parkin et al., 1992).Ultraviolet exposure and non-Hodgkin's Ilymphoma
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of changes in population exposure to UVR affected the two
cancers simultaneously. It is likely, however, that the UVR
effect upon incidence is considerably more delayed for MM
than that posited for NHL. Therefore, ifthe chronology were
known, it would be preferable to use appropriate time-
lagging.
The observed 2-fold excess of MM incidence in NHL
patients accords with an earlier report from the USA (Berg,
1967). This modest increase in risk also accords with another
recent finding which has been interpreted as suggesting a
shared influence of UVR exposure (Adami et al., 1995).
However, since the risk ofeach ofthese two cancers is known
to be increased by immunosuppression, it would not be
surprising if they showed some concurrence in individuals
experiencing immunosuppression, for whatever reason.
Further, the particular pattern observed here and by Adami
et al. (1995) may instead reflect the immunosuppressive effect
of therapy for NHL.
More generally, it is of interest that there have been few
reports of multiple primary cancers with a shared (non-
genetic) aetiology, with the exception of certain cancers
related to tobacco and alcohol or to hormonal-reproductive
factors (Schottenfeld, 1982). This apparent general absence of
concurrent aetiologically related cancers may reflect impor-
tant differences, at the individual level, in the particular
aspects of exposure that are aetiologically critical for each
cancer type. In this present example, episodic exposure to
UVR in childhood may be most important for lifetime risk of
MM (Armstrong and Kricker, 1995), whereas exposure to
UVR in adult life may be important for NHL. Hence, while
these two aspects of UVR exposure may not correlate
strongly at the individual level, they may still be positively
correlated at the population level. Any UVR-linked relation-
ship between these cancers would therefore be more evident
at the population level than at the individual level.
Most cancers have multifactorial causation, and many of
the aetiological influences are subtle and dependent on
context. One influence upon the risk of NHL may be
UVR-induced impairment of immune functioning. Although
the evolutionary adaptive significance of an immunosuppres-
sive effect of UVR exposure upon the immune system is not
known (Kripke, 1994), the effect is presumably not so large
as to become life-threatening in childhood and early
adulthood (e.g. via increased susceptibility to infectious
diseases). Therefore, the UVR-NHL relationship is unlikely
to be strong. If real, however, it would have implications for
any increases in UVR exposure that result from stratospheric
ozone depletion (Lloyd, 1993), particularly since it is the
shorter wavelengths of UV-B that are most increased by
stratospheric ozone depletion and which are most immuno-
suppressive in animals (Morison, 1989).
Further research to clarify this relationship should include
case-control studies of NHL in relation to recent and
lifetime UVR exposure, comparisons of NHL incidence in
occupational groups with known differences in UVR
exposure, and studies of the correlation between trends
(spatial, temporal) in NHL and non-melanoma skin cancers
(since these, apparently in contrast to MM, are substantially
affected by adult exposure to UVR).
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